'Drug eluting stents' presentation slideshows

BIODEGRADABLE METAL STENTS

BIODEGRADABLE METAL STENTS. Dinuka Bandara Niloy Ghosh Antoine Kaeslin Liz Zaharko. Click to Begin!. Abstract.

1.7k views • 99 slides

World Congress of Cardiology 2006

World Congress of Cardiology 2006. Valentin Fuster MD Director, Cardiovascular Institute Mount Sinai Medical Center, New York, NY. Christopher Cannon MD Staff Cardiologist Brigham and Women's Hospital,Boston, MA. James Ferguson MD Associate Director, Cardiology

704 views • 56 slides

Stent and Adjunctive Therapy Selection in 2010

Stent and Adjunctive Therapy Selection in 2010 . Ziyad Ghazzal MD, FACC, FSCAI Professor of Medicine Deputy VP/Dean; Associate Dean for Clinical Affairs American University of Beirut Adjunct Professor of Medicine Emory University School of medicine. The different types of DES on the market.

639 views • 52 slides

The DES controversy and DREAM

The DES controversy and DREAM. Eric J Topol MD Professor of Genetics Case Western Reserve University Cleveland, OH Robert M Califf MD Professor of Medicine Associate Vice Chancellor for Clinical Research Director, Duke Clinical Research Institute Duke University Medical Center Durham, NC.

631 views • 51 slides

Drug-eluting stents

672 views • 33 slides

Drug-eluting stents

654 views • 31 slides

Data Monitoring for Safety apparent harm with a new treatment ILLUMINATE trial

Evaluating Drug Safety in Clinical Trials (and Observational Registries) Stuart Pocock London School of Hygiene and Tropical Medicine.

415 views • 31 slides

337 views • 21 slides

Percutaneous coronary intervention (PCI)

Percutaneous coronary intervention (PCI). Coronary artery stenting. Dr Neil W. Bressloff. Coronary Artery Disease. Coronary Artery Disease (CAD) is a condition caused by the accumulation of plaque (usually atheromatous or fibrous plaque) on the inner walls of the artery.

1.05k views • 13 slides

Worldwide Coronary Stents Market 2018-2024

In order to estimate and validate the size of global coronary stents market, and to determine the size of other dependent submarkets, we have use both top-down and bottom-up approaches. The research study involved extensive use of secondary sources, directories, and databases, such as Hoovers, Factiva, One Source, Bloomberg, Reuters, and other government and private websites to identify and collect information useful for a technical, market-oriented, and commercial study of the global coronary stents market.

118 views • 8 slides

In-depth Analysis of Drug Eluting Stents Market

239 views • 6 slides

Drug Eluting Stent Market Size, Share, Analysis, Applications, Sale, Growth Insight, Trends and Forecast By 2024

The Drug Eluting Stent Market research report covers key players, trends, status, future forecast, size-share, development trends, challenges, opportunities and consumer behavioru2019s. It provides insight into the growth of value players, as well as looking at new entrants to the market and their growth prospects.

68 views • 6 slides

Coronary Stent Market Stock and Sales Analysis, Demands, Supply and Forecasts Report By 2024

The Global Coronary Stent Market is predicted to reach USD 15.18 billion by 2024 owing to factors include technological advancements, rising load of CAD, growing number of PCI procedures (percutaneous coronary intervention), increasing geriatric population and increasing demand for user-friendly procedures.

43 views • 4 slides

Coronary Stent Market Revenue, Growth Rate, Segment by Type Forecast 2024

Coronary Stent Market is predicted to reach USD 15.18 billion by 2024 owing to factors include technological advancements, rising load of CAD, growing number of PCI procedures increasing geriatric population and increasing demand for user-friendly procedures

36 views • 3 slides

Background

Background. Aims. Methods. Results.

86 views • 1 slides